You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Methscopolamine bromide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for methscopolamine bromide and what is the scope of freedom to operate?

Methscopolamine bromide is the generic ingredient in three branded drugs marketed by Bayshore Pharms Llc, Breckenridge Pharm, Chartwell Rx, Ne Rx Pharma, Pvt Form, and Fougera Pharms, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for methscopolamine bromide. Four suppliers are listed for this compound.

Summary for methscopolamine bromide
US Patents:0
Tradenames:3
Applicants:6
NDAs:6
Drug Master File Entries: 6
Finished Product Suppliers / Packagers: 4
Raw Ingredient (Bulk) Api Vendors: 67
Patent Applications: 1,586
What excipients (inactive ingredients) are in methscopolamine bromide?methscopolamine bromide excipients list
DailyMed Link:methscopolamine bromide at DailyMed
Pharmacology for methscopolamine bromide
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

US Patents and Regulatory Information for methscopolamine bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pvt Form METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 080970-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ne Rx Pharma METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 216786-002 Feb 1, 2024 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayshore Pharms Llc METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 200602-002 Sep 24, 2012 AA RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.